Literature DB >> 17334708

Xanthurenic aciduria due to a mutation in KYNU encoding kynureninase.

M Christensen1, M Duno, A M Lund, F Skovby, E Christensen.   

Abstract

Massive urinary excretion of xanthurenic acid, 3-hydroxykynurenine and kynurenine, known as xanthurenic aciduria or hydroxykynureninuria, in a young Somali boy suggested kynureninase deficiency. Mutation analysis of KYNU encoding kynureninase of the index case revealed homozygosity for a c.593 A > G substitution leading to a threonine-to-alanine (T198A) shift. A younger brother was found to have a similar excretion pattern and the same genotype. At present, neither of the two boys has symptoms of niacin deficiency. This is the first report linking xanthurenic aciduria to a mutation in the gene encoding kynureninase.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17334708     DOI: 10.1007/s10545-007-0396-2

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.750


  29 in total

Review 1.  Pellagra: dermatitis, dementia, and diarrhea.

Authors:  Juraj Hegyi; Robert A Schwartz; Vladimír Hegyi
Journal:  Int J Dermatol       Date:  2004-01       Impact factor: 2.736

Review 2.  Tryptophan nutrition and metabolism: an overview.

Authors:  J C Peters
Journal:  Adv Exp Med Biol       Date:  1991       Impact factor: 2.622

3.  Duarte-1 (Los Angeles) and Duarte-2 (Duarte) variants in Germany: two new mutations in the GALT gene which cause a GALT activity decrease by 40-50% of normal in red cells.

Authors:  Y S Shin; H G Koch; M Köhler; G Hoffmann; A Patsoura; T Podskarbi
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

Review 4.  Endogenous kynurenines as targets for drug discovery and development.

Authors:  Trevor W Stone; L Gail Darlington
Journal:  Nat Rev Drug Discov       Date:  2002-08       Impact factor: 84.694

5.  Enzyme activities involved in tryptophan metabolism along the kynurenine pathway in rabbits.

Authors:  A Bertazzo; E Ragazzi; M Biasiolo; C V Costa; G Allegri
Journal:  Biochim Biophys Acta       Date:  2001-08-15

6.  Lethal familial pellagra-like skin lesion associated with neurologic and developmental impairment and the development of cataracts.

Authors:  M A Salih; D A Bender; G M McCreanor
Journal:  Pediatrics       Date:  1985-11       Impact factor: 7.124

7.  Natural history of Hartnup disease.

Authors:  B Wilcken; J S Yu; D A Brown
Journal:  Arch Dis Child       Date:  1977-01       Impact factor: 3.791

8.  Enzyme activities of tryptophan metabolism along the kynurenine pathway in various species of animals.

Authors:  Graziella Allegri; Carlo V L Costa; Antonella Bertazzo; Monica Biasiolo; Eugenio Ragazzi
Journal:  Farmaco       Date:  2003-09

9.  Mutations in SLC6A19, encoding B0AT1, cause Hartnup disorder.

Authors:  Robert Kleta; Elisa Romeo; Zorica Ristic; Toshihiro Ohura; Caroline Stuart; Mauricio Arcos-Burgos; Mital H Dave; Carsten A Wagner; Simone R M Camargo; Sumiko Inoue; Norio Matsuura; Amanda Helip-Wooley; Detlef Bockenhauer; Richard Warth; Isa Bernardini; Gepke Visser; Thomas Eggermann; Philip Lee; Arthit Chairoungdua; Promsuk Jutabha; Ellappan Babu; Sirinun Nilwarangkoon; Naohiko Anzai; Yoshikatsu Kanai; Francois Verrey; William A Gahl; Akio Koizumi
Journal:  Nat Genet       Date:  2004-08-01       Impact factor: 38.330

10.  Familial hypertryptophanemia in two siblings.

Authors:  J R Martin; C S Mellor; F C Fraser
Journal:  Clin Genet       Date:  1995-04       Impact factor: 4.438

View more
  6 in total

1.  Comparison of tetrahydrofuran and ethyl acetate as extraction solvents for urinary organic acid analysis.

Authors:  Gy Wittmann; E Karg; A Mühl; O A Bodamer; S Túri
Journal:  J Inherit Metab Dis       Date:  2008-01-14       Impact factor: 4.982

2.  Severe intellectual disability, omphalocele, hypospadia and high blood pressure associated to a deletion at 2q22.1q22.3: case report.

Authors:  Milene Vianna Mulatinho; Cassio Luiz de Carvalho Serao; Fernanda Scalco; David Hardekopf; Sona Pekova; Kristin Mrasek; Thomas Liehr; Anja Weise; Nagesh Rao; Juan Clinton Llerena
Journal:  Mol Cytogenet       Date:  2012-06-11       Impact factor: 2.009

3.  New cases that expand the genotypic and phenotypic spectrum of Congenital NAD Deficiency Disorder.

Authors:  Justin O Szot; Anne Slavotinek; Karen Chong; Oliver Brandau; Marjan Nezarati; Anna M Cueto-González; Millan S Patel; Walter P Devine; Shannon Rego; Alicia P Acyinena; Patrick Shannon; Diane Myles-Reid; Susan Blaser; Tim V Mieghem; Halenur Yavuz-Kienle; Heyko Skladny; Kristen Miller; Miereia D T Riera; Silvia A Martínez; Eduardo F Tizzano; Lucie Dupuis; Dimitri James Stavropoulos; Vanda McNiven; Roberto Mendoza-Londono; Alison M Elliott; Robert S Phillips; Gavin Chapman; Sally L Dunwoodie
Journal:  Hum Mutat       Date:  2021-05-16       Impact factor: 4.700

Review 4.  The Plasma [Kynurenine]/[Tryptophan] Ratio and Indoleamine 2,3-Dioxygenase: Time for Appraisal.

Authors:  Abdulla A-B Badawy; Gilles Guillemin
Journal:  Int J Tryptophan Res       Date:  2019-08-21

Review 5.  Immunomodulatory Effects of Genetic Alterations Affecting the Kynurenine Pathway.

Authors:  Fanni A Boros; László Vécsei
Journal:  Front Immunol       Date:  2019-11-06       Impact factor: 7.561

6.  A Homozygous Deletion of Exon 5 of KYNU Resulting from a Maternal Chromosome 2 Isodisomy (UPD2) Causes Catel-Manzke-Syndrome/VCRL Syndrome.

Authors:  Isabel Schüle; Urs Berger; Uta Matysiak; Gunda Ruzaike; Brigitte Stiller; Martin Pohl; Ute Spiekerkoetter; Ekkehart Lausch; Sarah C Grünert; Miriam Schmidts
Journal:  Genes (Basel)       Date:  2021-06-07       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.